AMS:BMEAmadeus IT Group SA Class A Analysis
Data as of 2026-06-17 - not real-time
$1.43
Latest Price
8/10Risk
Risk Level: High
Executive Summary
American Shared Hospital Services (AMS) is trading at a deep discount to peers, with a forward P/E of 3.6 versus an industry average of 24.3 and a price‑to‑book of 0.39. The stock’s upside potential is estimated at 180% based on analyst targets of $4, while the current price sits at $1.43. Technicals show the price hovering just above the 20‑day SMA (1.416) but well below the 50‑day (1.476) and 200‑day (2.00) averages, indicating a bearish trend. RSI is at 48, suggesting neither overbought nor oversold conditions, and the MACD line has turned slightly bullish with a positive histogram. Volume is increasing, yet the market cap of under $10 M and average daily volume of ~200 K points to limited liquidity. Fundamentals reveal a 16% revenue growth year‑over‑year, but operating and profit margins remain negative (‑8.8% and ‑5.3% respectively), and the company carries a high debt‑to‑equity ratio of 78, with cash of only $3.5 M. The 30‑day volatility is extreme at 93%, and the beta is essentially neutral, underscoring the stock’s price sensitivity to market swings.
The recent shareholder meeting announcement has not yet translated into material operational change, leaving investors to weigh the sizable valuation discount against the company’s cash‑flow challenges and debt load. While the sector (medical care facilities) offers long‑term growth drivers, regulatory and execution risks remain elevated. Given the current risk profile, AMS may be attractive for patient, long‑term investors seeking a turnaround play, but short‑term traders should approach with caution.
The recent shareholder meeting announcement has not yet translated into material operational change, leaving investors to weigh the sizable valuation discount against the company’s cash‑flow challenges and debt load. While the sector (medical care facilities) offers long‑term growth drivers, regulatory and execution risks remain elevated. Given the current risk profile, AMS may be attractive for patient, long‑term investors seeking a turnaround play, but short‑term traders should approach with caution.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- price below 50‑day and 200‑day moving averages indicating bearish momentum
- RSI near 50 and modest MACD bullish signal insufficient to offset trend
- low liquidity and high volatility increase downside risk
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- substantial valuation discount relative to industry peers
- revenue growth of ~16% but persistent negative operating margins
- high debt load and limited cash raise concerns about sustainability
Long Term
> 3 yearsPositive
Model confidence: 5/10
Key Factors
- potential upside to $4 target representing ~180% upside
- industry demand for advanced radiosurgery equipment and services
- need for profitability improvement and cash‑flow generation to unlock value
Key Metrics & Analysis
Financial Health
Revenue Growth15.90%
Profit Margin-5.30%
P/E Ratio3.6
Debt/Equity78.27
P/B Ratio0.4
Industry P/E24.3
Technical Analysis
TrendBearish
RSI47.7
Support$1.28
Resistance$1.75
MA 20$1.42
MA 50$1.48
MA 200$2.00
MACDBullish
VolumeIncreasing
Fear & Greed Index88.5
Valuation
Target Price$4.00
Upside/Downside179.72%
GradeUndervalued
TypeValue
Risk Assessment
Beta-0.02
Volatility93.27%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.